Revenio Group Oyj

Helsinki Stock Exchange REG1V.HE

Revenio Group Oyj Price to Book Ratio (P/B) on January 14, 2025: 6.37

Revenio Group Oyj Price to Book Ratio (P/B) is 6.37 on January 14, 2025, a -4.05% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Revenio Group Oyj 52-week high Price to Book Ratio (P/B) is 9.53 on September 26, 2024, which is 49.56% above the current Price to Book Ratio (P/B).
Revenio Group Oyj 52-week low Price to Book Ratio (P/B) is 6.10 on April 25, 2024, which is -4.28% below the current Price to Book Ratio (P/B).
Revenio Group Oyj average Price to Book Ratio (P/B) for the last 52 weeks is 7.40.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Helsinki Stock Exchange: REG1V.HE

Revenio Group Oyj

CEO	Mr. Jouni Toijala B.Sc., M.B.A.
IPO Date	Oct. 2, 2001
Location	Finland
Headquarters	Äyritie 22
Employees	230
Sector	Consumer Discretionary
Industries Eyewear Medical Instruments Pharmaceuticals

Description

Revenio Group Oyj, a health technology company, designs, manufactures, and sells ophthalmic diagnostics and devices for the detection of glaucoma, macular degeneration, diabetic retinopathy, and cataracts in Finland, rest of Europe, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; DRSplus, a device for detection of diabetic retinopathy; iCare MAIA, a microperimeter to measure the visual field; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. It also provides Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

Key trends

Past 5 years